STU2 Antibody

What is STU2 and why is it important for microtubule research?

STU2 is a member of the XMAP215 family of conserved microtubule-binding proteins that regulate microtubule plus end dynamics in budding yeast. It plays essential roles in spindle formation and chromosome segregation, making it a critical target for cytoskeletal research . STU2 has the remarkable ability to function both as a microtubule polymerase and destabilizer, depending on cellular context .

This dual functionality makes STU2 particularly important for understanding fundamental mechanisms of microtubule regulation. The protein contains multiple functional domains including TOG domains that bind α/β-tubulin dimers, a coiled-coil domain responsible for dimerization, a microtubule-binding domain, and a C-terminal region that mediates interactions with other proteins such as Spc72 .

What are the main experimental applications for STU2 antibodies?

STU2 antibodies are valuable tools for multiple experimental approaches in yeast cell biology:

• Immunolocalization studies: For visualizing STU2 at spindle pole bodies (SPBs), kinetochores, and microtubule plus ends

• Co-immunoprecipitation assays: For identifying STU2 binding partners such as Spc72 and components of the γ-tubulin complex

• Western blotting: For quantifying STU2 levels and detecting specific mutant forms

• Chromatin immunoprecipitation: For studying STU2's association with kinetochores during mitosis

• Depletion verification: For confirming knockdown efficacy in auxin-inducible degron (AID) systems

When designing experiments with STU2 antibodies, it's important to note that some antibodies may detect certain forms of STU2 poorly. For example, research has shown that some anti-STU2 antibodies detect STU2-AID protein with reduced efficiency .

How do I select between polyclonal and monoclonal STU2 antibodies?

When studying specific domains of STU2, domain-specific antibodies can provide valuable insights. For instance, antibodies directed against TOG1/2 domains have been used to study STU2 mutants lacking other domains . Consider that domain-specific antibodies may not detect truncated forms of the protein, which can be useful for validating mutants but problematic for certain applications.

What are the optimal fixation and permeabilization conditions for STU2 immunofluorescence?

Optimal fixation conditions for STU2 immunofluorescence depend on which cellular structure you're targeting:

For SPB-associated STU2:

• 3.7% formaldehyde fixation for 15-20 minutes at room temperature

• Mild permeabilization with 0.1% Triton X-100 for 5 minutes

• Low-temperature methanol treatment (-20°C) may enhance accessibility to the C-terminal domain

For microtubule-associated STU2:

• Combined formaldehyde-glutaraldehyde fixation (3% formaldehyde, 0.1% glutaraldehyde)

• This preserves microtubule structure while maintaining protein antigenicity

• Permeabilization should be gentle to preserve microtubule integrity

Research has shown that STU2 localization can be distinctly identified at SPBs (co-localizing with Spc42) and along astral microtubules, with appropriate fixation methods . When analyzing STU2 at kinetochores, protocols must be optimized to distinguish this population from nearby microtubule plus ends.

How do I troubleshoot weak or absent STU2 antibody signal?

Common issues with STU2 detection and their solutions:

• Poor antibody recognition of modified STU2: Some antibodies detect modified forms (like STU2-AID) poorly . Solution: Use multiple antibodies targeting different epitopes or validate with tagged versions.

• Accessibility issues at SPBs: STU2 at the SPB may be obscured by other proteins. Solution: Increase permeabilization time or use epitope retrieval techniques.

• Fixation-dependent epitope masking: Solution: Test multiple fixation protocols (formaldehyde, methanol, glutaraldehyde combinations).

• Low abundance at specific cell cycle stages: Solution: Synchronize cells or use cell cycle markers to identify appropriate cells.

• Protein degradation during sample preparation: Solution: Include protease inhibitors and process samples quickly at cold temperatures.

If signal remains weak, consider amplification strategies such as tyramide signal amplification (TSA) or using secondary antibody enhancement systems.

How can I use STU2 antibodies to distinguish between its kinetochore and microtubule functions?

STU2 performs distinct functions at kinetochores and microtubule plus ends. To distinguish between these roles:

Approach 1: Domain-specific antibodies

• Use antibodies against the C-terminal domain (amino acids 853-888) to study Spc72 interactions at SPBs

• Use antibodies against the middle domain to study microtubule binding

• Use antibodies against TOG domains to examine tubulin binding functions

Approach 2: Co-localization studies

• Combine STU2 antibodies with kinetochore markers (e.g., Ndc80 complex components)

• Use spindle pole body markers (e.g., Spc42-CFP) to identify STU2 at spindle poles

• Employ microtubule plus end markers (e.g., Bim1) to distinguish plus end populations

Approach 3: Mutant analysis

• Compare antibody localization in wild-type cells versus cells expressing STU2 truncation mutants

• STU2 lacking its C-terminal domain (STU2 1-855) fails to bind SPBs but retains some MT plus end association

• The coiled-coil domain is required for kinetochore association

Research demonstrates that STU2 at kinetochores plays a crucial role in chromosome biorientation and tension sensing, while its activity at microtubule plus ends affects dynamic instability .

What controls should I include when using STU2 antibodies?

Essential controls for STU2 antibody experiments:

• Negative controls:

  • STU2 deletion strains (though since STU2 is essential, you'll need conditional mutants)

  • Auxin-treated STU2-AID cells for complete depletion

  • Secondary antibody only control for autofluorescence assessment

• Specificity controls:

  • Pre-adsorption with recombinant STU2 protein

  • Peptide competition assays with the immunizing peptide

  • Domain deletion mutants (e.g., STU2 1-855) to confirm domain-specific antibodies

• Positive controls:

  • GFP-tagged STU2 with anti-GFP antibodies for co-localization

  • Known cell cycle stage with predictable STU2 localization

  • Cells arrested in metaphase (e.g., using Cdc20 depletion) where STU2 shows distinct localization patterns

When using STU2 antibodies in co-immunoprecipitation experiments, include input controls, IgG controls, and reciprocal immunoprecipitations to validate interactions with binding partners like Spc72, γ-TuSC components, or Kar9 .

How can I use STU2 antibodies to investigate its role in microtubule nucleation?

STU2 promotes oligomerization of the γ-tubulin complex and functions in microtubule nucleation . To study this specific function:

Experimental approach:

• Use synchronized cells to examine STU2's role during specific cell cycle stages

• Employ co-immunoprecipitation with STU2 antibodies to isolate complexes containing γ-TuSC components (Spc97, Spc98, Tub4)

• Perform immunofluorescence after microtubule regrowth assays (post-nocodazole washout) to visualize STU2's role in de novo nucleation

Key methodological considerations:

• Time course experiments are crucial as STU2's nucleation activity is rapid and may be transient

• When studying cytoplasmic microtubule (cMT) nucleation, examine cells after nocodazole washout

• For distinguishing STU2's nucleation versus stabilization roles, compare early timepoints (0-5 min) versus later timepoints (15-60 min) after washout

Research has demonstrated that STU2's microtubule binding domain interacts with γ-TuSC, while its TOG domains bind α/β-tubulin dimers . Analyzing these distinct interactions can reveal how STU2 coordinates microtubule nucleation.

How can I design experiments to distinguish between STU2's polymerase and destabilizing activities?

STU2 has the remarkable ability to act as either a polymerase or destabilizer of microtubule plus ends . To distinguish between these opposing functions:

Approach 1: Tension-dependent studies

• Use metaphase-arrested cells with labeled kinetochores and microtubules

• Compare STU2 activity at tension-bearing versus tension-free kinetochore-microtubule attachments

• STU2 may act as a destabilizer at low-tension attachments but switch to a polymerase under high tension

Approach 2: Domain-specific mutations

• Generate cells expressing STU2 with mutations in specific domains:

  • TOG domain mutants (STU2 TOGAA) affect polymerase activity

  • Coiled-coil deletion affects dimerization and function

  • C-terminal truncation affects localization

• Use STU2 antibodies to confirm localization of these mutants and correlate with observed phenotypes

Approach 3: In vitro reconstitution

• Purify STU2 and components of kinetochore complexes

• Reconstitute interactions on dynamic microtubules and visualize effects

• Add tension using micromanipulation and observe changes in STU2 activity

Research has shown that the TOG domains and the dimerizing coiled-coil domain of STU2 are most important for cytoplasmic microtubule formation, while the microtubule binding domain has a significant impact on this process .

What approaches can be used to study STU2's essential kinetochore functions?

STU2 plays an essential role at kinetochores that is independent of its role in regulating microtubule dynamics . To investigate this specific function:

Genetic approaches:

• Utilize the lethal STU2 mutant that lacks proper interactions with binding partners

• Study artificial tethering of STU2 to the C-terminus of Nuf2 (component of outer kinetochore Ndc80 complex)

• Compare with tethering to other known STU2 interactors to demonstrate the specificity of its kinetochore function

Cytological approaches:

• Measure inter-kinetochore distances as indicators of tension

• Analyze spindle length in metaphase-arrested cells (using Spc42-CFP markers)

• Examine kinetochore-microtubule attachment stability under various conditions

Biochemical approaches:

• Perform co-immunoprecipitation with STU2 antibodies to identify kinetochore-specific binding partners

• Use cross-linking approaches to capture transient interactions

• Employ proximity labeling techniques to identify proteins near STU2 at kinetochores

Research has demonstrated that STU2 may confer tension sensitivity to kinetochores by destabilizing attachments at low tension, an activity that is suppressed when the outer kinetochore structure stretches under high tension .

How do I interpret changes in STU2 localization throughout the cell cycle?

STU2 localization changes dynamically during the cell cycle, which can complicate data interpretation. Here's how to analyze these patterns:

When interpreting immunofluorescence data:

• Always use cell cycle markers to accurately determine cell cycle stage

• Quantify signal intensity at different locations to track redistribution

• Be aware that fixation artifacts can alter apparent localization

• Consider that not all STU2 populations may be equally accessible to antibodies

Research demonstrates that STU2 is part of larger complexes including the Tub4 complex, Spc72, and other proteins, which may affect antibody accessibility in different cellular contexts .

How can I distinguish between true STU2 signals and artifacts in my experiments?

Distinguishing genuine STU2 signals from artifacts requires systematic validation:

• Perform knockout/knockdown controls:

  • Use STU2-AID strains treated with IAA to confirm signal specificity

  • Compare wild-type with domain deletion variants (e.g., STU2 1-855)

• Use orthogonal detection methods:

  • Compare antibody signals with GFP-tagged STU2 localization

  • Validate with different antibodies targeting distinct epitopes

  • Confirm key findings with complementary techniques (e.g., biochemical fractionation)

• Analyze signal characteristics:

  • True STU2 signals should change predictably with cell cycle progression

  • Signal intensity should correlate with expression levels in different genetic backgrounds

  • Signal should co-localize with known interacting partners (e.g., Spc72 at SPBs)

• Check for common artifacts:

  • Nonspecific nuclear rim staining (common with certain fixation methods)

  • Spindle pole body aggregation artifacts in overexpression studies

  • Background fluorescence from cell wall components in yeast

Research has noted that for unknown reasons, some anti-STU2 antibodies detect modified forms like STU2-AID protein poorly, which must be considered when interpreting negative results .

How can I use STU2 antibodies to investigate its interaction with the γ-tubulin complex?

STU2 interacts with the γ-tubulin complex (γ-TuSC) and influences its activity in microtubule nucleation . To study this interaction:

Co-immunoprecipitation approach:

• Use anti-STU2 antibodies to pull down STU2 and associated proteins

• Probe for γ-TuSC components (Tub4, Spc97, Spc98) by Western blotting

• Perform reciprocal immunoprecipitation with antibodies against γ-TuSC components

Research has demonstrated that STU2 binds to the γ-TuSC with high affinity (Kd of 63.4 nM) and that this interaction is mediated by STU2's MT binding region (amino acids 451-684), not its TOG domains .

Domain mapping approach:

• Generate recombinant fragments of STU2 (TOG domains, MT binding region)

• Perform in vitro binding assays with purified γ-TuSC

• Use antibodies specific to different STU2 domains to validate the interactions

Functional analysis:

• Deplete endogenous STU2 using an auxin-inducible degron system

• Express domain-specific STU2 mutants and analyze their ability to interact with γ-TuSC

• Correlate these interactions with functional outcomes in microtubule organization

Research has shown that Stu2 enhances the Spc72–γ-TuSC interaction by binding to both Spc72 and γ-TuSC, forming a larger complex that facilitates microtubule nucleation .

What methods can I use to study STU2's role in kinetochore-microtubule attachments?

STU2 plays a crucial role in establishing and regulating kinetochore-microtubule attachments . To investigate this function:

Approach 1: Visualizing attachment stability

• Perform live imaging of cells expressing fluorescently-tagged kinetochore components and STU2

• Use STU2 antibodies in fixed cells to correlate STU2 levels with attachment stability

• Measure inter-kinetochore distance as a proxy for tension

Approach 2: Biochemical characterization

• Use STU2 antibodies to immunoprecipitate kinetochore-associated complexes

• Identify components that associate with STU2 specifically during metaphase

• Compare wild-type STU2 with coiled-coil deletion mutants that fail to associate with kinetochores

Approach 3: Genetic manipulation

• Engineer the lethal STU2 mutant that lacks proper interactions with binding partners

• Artificially tether this mutant to the Ndc80 complex component Nuf2

• Analyze restoration of cell viability and chromosome segregation fidelity

Research has demonstrated that STU2 may confer tension sensitivity to kinetochores by competing with or inhibiting microtubule binding of other elements at the kinetochore, such as the CH domains of the Ndc80 complex or the Dam1 complex .

How can STU2 antibodies help investigate evolutionary conservation of XMAP215 family functions?

STU2 belongs to the conserved XMAP215 family of microtubule regulators. STU2 antibodies can help explore evolutionary conservation:

Cross-species comparative studies:

• Test cross-reactivity of STU2 antibodies with homologs in related yeasts

• Analyze conservation of binding partners and functional domains

• Compare localization patterns across species to identify conserved and divergent functions

Functional complementation approaches:

• Express mammalian or other yeast XMAP215 homologs in STU2-depleted cells

• Use antibodies to verify expression and localization

• Correlate with functional rescue to identify conserved functional domains

Structure-function analysis:

• Generate chimeric proteins combining domains from different species

• Use domain-specific antibodies to confirm expression and localization

• Analyze functional outcomes to map evolutionarily conserved interaction sites

Research suggesting that STU2's kinetochore function may be distinct from its microtubule polymerase activity provides a framework for investigating whether this functional separation is conserved across species .

What are emerging methods for studying STU2 dynamics and interactions in live cells?

While antibodies are primarily used in fixed cells, new approaches can complement antibody-based studies of STU2:

Advanced imaging approaches:

• Single-molecule techniques to track individual STU2 molecules

• Fluorescence Recovery After Photobleaching (FRAP) to measure dynamics

• Förster Resonance Energy Transfer (FRET) to measure proximity to binding partners

Proximity labeling methods:

• BioID or TurboID fusions to identify proteins in close proximity to STU2

• Split-BioID to identify context-specific interactions

• Validation of identified interactions using traditional antibody approaches

Optogenetic manipulation:

• Light-inducible protein interaction systems to control STU2 localization

• Rapid induction or disruption of specific interactions

• Correlation with functional outcomes in microtubule dynamics

These emerging methods can provide temporal resolution that complements the spatial information from antibody-based techniques, offering new insights into the dynamic functions of STU2 in living cells.